EXCLUSIVE-MODERNA'S COVID-19 VACCINE UNLIKELY TO WIN REGULATORY APPROVAL IN JAPAN UNTIL MAY, DISTRIBUTOR TAKEDA SAYS
Stock Market News
- Stock Market
- Stock Market News
- Economy
- Moderna's Covid-19 Vaccine Unlikely To Win Regulatory Approval In Japan Until May, Distributor Takeda Says